Integrin αVβ3 contains a receptor site for resveratrol

Resveratrol is a naturally occurring polyphenol, which causes apoptosis in cultured cancer cells. We describe a cell surface resveratrol receptor on the extracellular domain of hetero‐dimeric αVβ3 integrin in MCF‐7 human breast cancer cells. This receptor is linked to induction by resveratrol of extracellular‐regulated kinases 1 and 2 (ERK1/2)‐ and serine‐15‐p53‐dependent phosphorylation leading to apoptosis. The integrin receptor is near the Arg‐Gly‐Asp (RGD) recognition site on the integrin; an integrin‐binding RGD peptide inhibits induction by resveratrol of ERK1/2‐and p53‐dependent apoptosis. Antibody (Ab) to integrin αVβ3, but not to αVβ5, inhibits activation by resveratrol of ERK1/2 and p53 and consequent apoptosis in estrogen receptor‐α (ERα) positive MCF‐7, and ERα‐negative MDA‐MB231 cells. Resveratrol is displaced from the purified integrin by an RGD, but not RGE, peptide, and by αVβ3 integrin‐specific Ab. Resveratrol action is blocked by siRNAβ3, but not by siRNAαV. [14C]‐Resveratrol binds to commercially purified integrin αVβ3 and to αVβ3 prepared from MCF‐7 cells;binding of [14C]‐resveratrol to the β3, but not to the αV monomer, is displaced by unlabeled resveratrol. In conclusion, binding of resveratrol to integrin αVβ3, principally to the β3 monomer, is essential for transduction of the stilbene signal into p53‐dependent apoptosis of breast cancer cells.—Lin, H.‐Y., Lansing, L., Merillon, J.‐M., Davis, F. B., Tang, H.‐Y., Shih, A., Vitrac, X., Krisa, S., Keating, T., Cao, H. J., Bergh, J., Quackenbush, S., Davis, P. J. Integrin αVβ3 contains a receptor site for resveratrol. FASEB J. 20, E1133–E1138 (2006)

[1]  M. Berger,et al.  Integrin beta3 overexpression suppresses tumor growth in a human model of gliomagenesis: implications for the role of beta3 overexpression in glioblastoma multiforme. , 2004, Cancer research.

[2]  D. Hicklin,et al.  Elevated Flk1 (Vascular Endothelial Growth Factor Receptor 2) Signaling Mediates Enhanced Angiogenesis in β3-Integrin–Deficient Mice , 2004, Cancer Research.

[3]  N. Seeram,et al.  Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. , 2004, Anticancer research.

[4]  Hung-Yun Lin,et al.  Resveratrol induced serine phosphorylation of p53 causes apoptosis in a mutant p53 prostate cancer cell line. , 2002, The Journal of urology.

[5]  F. B. Davis,et al.  Oestrogen inhibits resveratrol-induced post-translational modification of p53 and apoptosis in breast cancer cells , 2004, British Journal of Cancer.

[6]  Li Zhang,et al.  Ligand Binding to Integrins* , 2000, The Journal of Biological Chemistry.

[7]  Sarah A. Boswell,et al.  Inhibitory effect of epidermal growth factor on resveratrol-induced apoptosis in prostate cancer cells is mediated by protein kinase C-alpha. , 2004, Molecular cancer therapeutics.

[8]  J. Goellner,et al.  Development of monoclonal antibodies against the human sodium iodide symporter: immunohistochemical characterization of this protein in thyroid cells. , 1999, The Journal of clinical endocrinology and metabolism.

[9]  J. Pezzuto,et al.  Resveratrol exhibits cytostatic and antiestrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells. , 2001, Cancer research.

[10]  Hung-Yun Lin,et al.  Integrin alphaVbeta3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis. , 2005, Endocrinology.

[11]  M. Tsan,et al.  Resveratrol induces Fas signalling‐independent apoptosis in THP‐1 human monocytic leukaemia cells , 2000, British journal of haematology.

[12]  D. Ribatti,et al.  Biological and molecular properties of a new αvβ3/αvβ5 integrin antagonist , 2005, Molecular Cancer Therapeutics.

[13]  Z. Dong,et al.  Involvement of c‐jun NH2‐terminal kinases in resveratrol‐induced activation of p53 and apoptosis , 2002, Molecular carcinogenesis.

[14]  R. Ghidoni,et al.  Resveratrol as an anticancer nutrient: molecular basis, open questions and promises. , 2005, The Journal of nutritional biochemistry.

[15]  I. Newsham,et al.  Influence of p53 and caspase 3 activity on cell death and senescence in response to methotrexate in the breast tumor cell. , 2004, Biochemical pharmacology.

[16]  F. B. Davis,et al.  Thyroid hormone induces activation of mitogen-activated protein kinase in cultured cells. , 1999, The American journal of physiology.

[17]  F. B. Davis,et al.  Thyroid hormone causes mitogen-activated protein kinase-dependent phosphorylation of the nuclear estrogen receptor. , 2004, Endocrinology.

[18]  Hong Zhu,et al.  Upregulation of endogenous antioxidants and phase 2 enzymes by the red wine polyphenol, resveratrol in cultured aortic smooth muscle cells leads to cytoprotection against oxidative and electrophilic stress. , 2006, Pharmacological research.

[19]  Phuong Chung,et al.  Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan , 2003, Nature.

[20]  J. Mérillon,et al.  Carbon-14 biolabelling of wine polyphenols in Vitis vinifera cell suspension cultures. , 2002, Journal of biotechnology.

[21]  G. Hu,et al.  Trans-resveratrol, a red wine ingredient, inhibits voltage-activated potassium currents in rat hippocampal neurons , 2005, Brain Research.

[22]  F. B. Davis,et al.  Thyroid hormone induces activation of mitogen-activated protein kinase in cultured cells. , 1999, American journal of physiology. Cell physiology.